Archives

  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-04
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • Polyethylenimine Linear: Optimized DNA Transfection with ...

    2026-04-05

    Polyethylenimine Linear: Optimized DNA Transfection with PEI MW 40,000

    Introduction and Principle: Why PEI MW 40,000?

    Polyethylenimine Linear (PEI), MW 40,000, has emerged as a gold-standard DNA transfection reagent for in vitro studies—delivering reliable, high-efficiency gene transfer across diverse mammalian cell models. This linear polyethylenimine transfection reagent acts as a positively charged DNA carrier, condensing nucleic acids into compact, positively charged complexes. These complexes interact with the cell surface, leveraging endocytosis-mediated DNA uptake to facilitate entry into cells. Notably, the reagent is serum-compatible, enabling high transfection efficiencies (60–80%) even in complex culture conditions. PEI MW 40,000 is widely used for transient gene expression, recombinant protein production, and functional gene study transfection—from high-throughput 96-well screens to large-scale bioreactor runs up to 100 liters.

    APExBIO supplies Polyethylenimine Linear (PEI), MW 40,000 as a ready-to-use solution, ensuring reproducible performance and streamlined experimental setup. Its robust mechanism and scalability make it a core molecular biology transfection reagent for HEK-293, HEK293T, CHO-K1, HepG2, and HeLa cell applications.

    Step-by-Step Workflow: Protocol Enhancements for Superior Results

    1. Preparation of PEI-DNA Complexes

    • Stock Solution Handling: Thaw the PEI solution (2.5 mg/mL) and equilibrate to room temperature. For frequent use, store aliquots at 4°C to minimize freeze-thaw cycles (transfection reagent storage 4°C), with long-term reserves at -20°C (transfection reagent storage -20°C).
    • DNA to PEI Ratio: Optimal DNA condensation polymer activity typically occurs at an N:P (nitrogen:phosphate) ratio of 10:1 for most cell lines. Fine-tune this ratio for your specific system to balance transfection efficiency and cytotoxicity.
    • Complexation: Dilute DNA and PEI separately in a serum-free buffer (e.g., 150 mM NaCl or Opti-MEM). Combine, vortex briefly, and incubate for 10–20 minutes at room temperature to allow complete DNA complexation.

    2. Application to Cell Culture

    • Cell Density: For adherent lines like HEK-293, CHO-K1, or HeLa, seed cells to reach 70–90% confluence at the time of transfection.
    • Serum Compatibility: Add PEI-DNA complexes directly to culture medium—no need to remove serum—making this a serum-compatible transfection reagent ideal for sensitive or primary cells.
    • Incubation: Allow complexes to incubate for 4–6 hours before refreshing the medium. Expression analysis can typically begin 24–48 hours post-transfection.

    3. Scale-Up for High-Throughput and Bioreactor Runs

    • Miniaturization: The protocol scales efficiently from 96-well plates to T-flasks and roller bottles. Adjust reagent volumes and DNA input proportionally.
    • Large-Scale Bioreactor Transfection: For applications up to 100 liters, PEI MW 40,000 maintains high reproducibility, supporting industrial recombinant protein production transfection and gene therapy research (see this comparative review for workflow integration strategies).

    Advanced Applications and Comparative Advantages

    Transfection Versatility: From Epigenetics to Neuroinflammation

    PEI MW 40,000 demonstrates exceptional transfection efficiency (60–80%) across standard and challenging cell types. Its proven track record includes:

    • HEK-293 transfection: Industry benchmark for transient gene expression reagent workflows.
    • CHO-K1 cell transfection reagent: Reliable for therapeutic protein and antibody production.
    • HepG2 and HeLa cell transfection reagent: Used in metabolic, cancer, and functional genomics research.
    • Neuroinflammatory and Epigenetic Studies: As highlighted in Li et al. (2025, Journal of Neuroinflammation), PEI-mediated transfection enabled precise manipulation of astrocyte gene expression to dissect the role of H3K18 lactylation and NOD2 in bilirubin-induced pyroptosis. This application underscores the reagent’s utility for both routine and advanced research questions.

    Mechanistic Superiority

    PEI MW 40,000’s unique linear structure offers a balance between DNA complex stability and cellular uptake. This aligns with findings from "Mechanistic Mastery", which complements the current article by detailing the molecular mechanisms behind endocytosis mediated DNA uptake and how this underpins both transfection efficiency and low cytotoxicity. In contrast, "Epigenetic Tool" extends these insights to discuss PEI’s role in epigenetic and neuroinflammatory models, reinforcing its versatility for cutting-edge research.

    Advantages Over Alternatives

    • Serum Compatibility: Unlike many cationic lipid reagents, PEI supports robust transfection in serum-containing media, protecting cells from stress and supporting sensitive lines.
    • Scalability: From microplates to bioreactor transfection, PEI MW 40,000 adapts effortlessly, enabling both high-throughput screens and industrial-scale applications.
    • Cost-Efficiency: As a DNA delivery polymer, PEI offers high performance without the premium pricing of some commercial lipid-based reagents.

    Troubleshooting and Optimization Tips

    Maximizing Transfection Efficiency and Minimizing Cytotoxicity

    1. Optimize N:P Ratio: Start with an N:P ratio of 10:1 but titrate to find the sweet spot for your system. Too much PEI may increase toxicity; too little may reduce DNA delivery.
    2. DNA Quality: Use endotoxin-free, highly purified plasmid DNA. Contaminants can reduce transfection efficiency and cell viability.
    3. Complex Formation Buffer: Use a neutral salt buffer (e.g., 150 mM NaCl). Avoid buffers with divalent cations or serum, which may destabilize complexes.
    4. Cell Health: Transfect actively dividing cells at optimal confluence. Over-confluence or poor viability reduces uptake.
    5. Incubation Time: If toxicity is observed, shorten the exposure of cells to PEI-DNA complexes before media change.
    6. Batch Consistency: Purchase PEI from trusted suppliers like APExBIO to ensure batch-to-batch reproducibility, as highlighted in recent comparative analyses.

    Common Issues and Solutions

    • Low Transfection Efficiency: Check DNA quality, optimize N:P ratio, and ensure correct cell density. Consider a brief gentle centrifugation step after adding complexes to promote cell contact.
    • High Cytotoxicity: Reduce PEI amount or incubation time, and confirm with a viability assay (e.g., MTT or Trypan Blue).
    • Inconsistent Results: Standardize all variables—DNA prep, PEI lot, buffer composition, and cell passage number. Store PEI as recommended (transfection reagent storage -20°C / transfection reagent storage 4°C).
    • Scaling Up: Maintain proportional reagent volumes and ensure adequate mixing. For large-volume applications, pre-mix PEI-DNA complexes in advance and add gradually to avoid localized toxicity.

    Future Outlook: Expanding the Frontier of DNA Delivery Polymers

    The molecular biology landscape is rapidly evolving, with increasing demand for scalable, reproducible, and versatile DNA transfection reagents. Polyethylenimine Linear (PEI), MW 40,000, is uniquely positioned to bridge the gap between discovery research and translational applications—from basic mechanistic studies to therapeutic protein production and emerging gene therapies. Its compatibility with serum, broad cell-type utility, and scalability make it a workhorse for both academic and industrial laboratories.

    Recent studies, such as Li et al. (2025), exemplify how PEI MW 40,000 enables sophisticated modeling of neuroinflammatory and epigenetic pathways, providing insights into disease mechanisms and therapeutic avenues. As new gene editing, mRNA delivery, and cell therapy technologies emerge, PEI’s modularity and proven track record will continue to support innovation at the interface of cell biology and translational medicine.

    For researchers seeking a reliable, cost-effective, and high-performing cationic polymer for nucleic acid delivery, Polyethylenimine Linear (PEI), MW 40,000 from APExBIO offers a thoroughly validated solution, backed by extensive literature and real-world success. Whether your goal is transient gene expression, large-scale recombinant protein production, or cutting-edge functional genomics, this reagent will continue to set the benchmark for molecular biology transfection workflows.